In laboratory studies, scientists at the Johns Hopkins Kimmel Cancer Center have developed a way to personalize chemotherapy drug selection for cancer patients by using cell lines created from their own tumors.
‘We aim to develop an understanding of which novel research activities could bring benefits for patients,’ explained Professor Christof von Kalle, Director of the Department of Translational Oncology, NCT (German National Centre for Tumour Diseases) and the German Cancer Research Centre (DKFZ), speaking on translational activities during the New Cancer Targets gathering in Heidelberg this…
‘The disease “cancer” is increasingly classified into sub-groups. Today, we are already dealing with a number of orphan diseases,’ says Professor Richard Greil MD, head of LIMCR at University Hospital Salzburg.
A dynamic new consortium was launched in October during the recent Innovation in Oncology event organised by the German Cancer Research Centre (DKFZ) with Heidelberg University Hospital.
BRAF is a protein that plays an important part in the transmission of growth signals. In a mutated state it can lead to uncontrolled cell growth. Around every second malignant melanoma – the deadliest and most aggressive form of skin cancer – has a certain mutation of the BRAF gene.
French and German experts hear of a possible new computer-based system to identify new biomarkers for colon cancer.
Individually customised drug therapies have been used for the last two years, particularly for cancer patients
Prostate cancer is the second leading cause of death among men yet remains one of the most frustrating for physicians to find and treat. Merging the strengths of imaging modalities helps, but does not solve all the problems, says John Brosky
Germany hopes for better research conditions as revision of the EU Clinical Trials Directive is nigh
Using advanced microscopes equipped with tissue-penetrating laser light, cancer imaging experts at Johns Hopkins have developed a promising, new way to accurately analyze the distinctive patterns of ultra-thin collagen fibers in breast tumor tissue samples and to help tell if the cancer has spread.
Personalised cancer medicine is much discussed, with high expectations for biomolecular decoding of various tumours and the global pharma industry developing targeted drugs to attack tumours at a biomolecular level.
The first International Day of Radiology (IDoR) will be celebrated on November 8, as participating societies from all over the world will host a series of events to highlight the role played by radiology in modern medicine and help raise the public profile of the radiologist.
IBA Group, a leader in advanced cancer diagnosis and therapy technologies, and Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced their first-ever installation of a state-of-the-art, patient-centered proton therapy treatment room in the United States.
Launch of collaboration marked with development of new treatment protocol for trans-arterial embolization in hypervascular tumors.
Modern wars will be fought in the cyber zone, targeting an enemy's communications technology to cause critical damage; a Tel Aviv University researcher suggests to employ similar tactics in the battle against cancer.
Cancer specialists everywhere increasingly face new findings from molecular biology. Genetic profiling of tumours opens up entirely new perspectives on the disease. How to cope with and integrate new insights into cancer diagnosis and treatment was among key issues discussed at the 2nd European Forum on Oncology, held in Berlin this May
Enormous technical developments over recent decades, along with greater understanding of tumour biology, have made imaging, pathology and laboratory medicine indispensable tools in personalised cancer treatments.
For some, ‘life’s a bitch’ with unfairness and suffering an integral part of it. Many more people actually do not expect any better than the barrenness and misery in which they live, EH Malta Correspondent Moira Mizzi reflects.
Findings from the landmark National Lung screening Trial (NLST) continue to make waves in the United States, and increasingly around the world. The principal investigator for the component of the NLST sponsored by the American College of Radiology Imaging Network (ACRIN), Denise Aberle, MD, said the NLST can provide a road map for public policy regarding lung cancer screening, though she cautions…
Breast cancer is the most common cancer in women in Europe: each year 350,000 new cases are diagnosed and each year about 130,000 women die of the disease. At the same time breast cancer is one of the few cancer types with encouraging healing prospects – if detected early.
Until now, interventional and endoscopic therapies have held little importance in common cancer treatment. However, given the trend towards personalised medicine and targeted cancer therapy, increasing attention is being paid to reasonable complements to traditional cancer surgery.
Although modern respirators present ever increasing features to enhance and simplify ventilation therapy, methods to quantify the efficacy of ventilator changes are limited.